News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma
Dec 24, 2024, 14:29

Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma

Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology, shared a post on X:

“Advanced urothelial carcinoma patients with TSC1 mutations show higher response rates to EV monotherapy (87% vs. 51%), while presence of CDKN2A/B is neg associated with PFS (4.6 vs. 6 ) mo. (Nectin4 is not available).”

Enfortumab

Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data

Authors: Tanya Jindal et al.

Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma

advanced urothelial carcinoma Ajjai Alva Ali Raza Khaki. Amanda Nizam Arnab Basu Cameron Pywell cancer Charles Nguyen Christopher Hoimes Cindy Jiang Deepak Kilari Dimitra Bakaloudi Dory Freeman Emily Lemke Hamid Emamekhoo Joaquim Bellmunt Laura Bukavina Matthew Davidsohn Matthew I. Milowsky Matthew T Campbell Mehmet A Bilen Michael Glover Nancy B. Davis Omar Alhalabi OncoDaily Oncology Pedro C Barata Petros Grivas Rafee Talukder Rohit Bose Sean Evans Shilpa Gupta Sumit A. Shah Tanya Jindal Vadim S Koshkin Woogwang Sim Yousef Zakharia
Special Coverage
Drugs
Dec 24, 2024, 14:29
Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma
Opinion
Dec 24, 2024, 14:25
Portia Smallbone: HCT in patients with MF and splanchnic vein thrombosis
Science
Dec 24, 2024, 14:23
Myeloma Paper of the Day, December 24th, suggested by Robert Orlowski
Science
Dec 24, 2024, 14:08
Jennifer A. Marks: Oncologist’s decision-making from a psychosocial perspective
Blog
Dec 24, 2024, 14:04
Yvonne Diaz: The genesis for the Hear Her campaign
Science
Dec 24, 2024, 14:02
Stephanie Graff: Abemaciclib Plus Fulvestrant in Advanced Breast Cancer
Science
Dec 24, 2024, 13:45
Naveen Pemmaraju: Transfusions with rare antibody profiles during leukemia management
Science
Dec 24, 2024, 13:29
Francesco Schettini: Which ADC is to prioritise in HR+ and TN BC?
Science
Dec 24, 2024, 13:21
Total Body Irradiation vs Chemotherapy for Hematopoietic Stem Cell Transplant in Adult AML
Blog
Dec 24, 2024, 13:16
Revolutionizing Cancer Screening: Oatmeal Health's Mission to Bridge the Healthcare Gap
Blog
Dec 24, 2024, 13:12
Guru Sonpavde: Phase I clinical trial unit update from Advent Health Central Florida Cancer Institute
Career
Dec 24, 2024, 12:28
OncoInfluencers to Follow on Social Media: Fadi Haddad